C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235,273 | -39.7% | 126,491 | -10.8% | 0.00% | 0.0% |
| Q2 2023 | $389,972 | +96908.0% | 141,808 | +10.8% | 0.00% | 0.0% |
| Q1 2023 | $402 | -46.8% | 127,994 | -0.1% | 0.00% | -50.0% |
| Q4 2022 | $756 | -99.9% | 128,087 | +2.1% | 0.00% | -50.0% |
| Q3 2022 | $1,100,000 | +16.2% | 125,404 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $947,000 | -68.8% | 125,579 | +0.4% | 0.00% | -63.6% |
| Q1 2022 | $3,033,000 | – | 125,030 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $17,795,000 | 7.09% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $60,745,000 | 3.44% |
| Soleus Capital Management, L.P. | 464,068 | $17,166,000 | 3.09% |
| Cormorant Asset Management, LP | 2,490,065 | $92,107,000 | 2.05% |
| P.A.W. CAPITAL CORP | 50,000 | $1,850,000 | 1.63% |
| Perceptive Advisors | 3,158,566 | $116,835,000 | 1.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 497,136 | $18,389,000 | 1.41% |
| Mizuho Securities Co. Ltd. | 169,392 | $6,266,000 | 1.30% |
| RTW INVESTMENTS, LP | 2,149,228 | $79,437,000 | 1.24% |
| Darwin Global Management, Ltd. | 140,034 | $5,180,000 | 1.01% |